OA09772A - "mometasone furoate monohydrate, process for making same and pharmaceutical compositions". - Google Patents

"mometasone furoate monohydrate, process for making same and pharmaceutical compositions".

Info

Publication number
OA09772A
OA09772A OA60348A OA60348A OA09772A OA 09772 A OA09772 A OA 09772A OA 60348 A OA60348 A OA 60348A OA 60348 A OA60348 A OA 60348A OA 09772 A OA09772 A OA 09772A
Authority
OA
OAPI
Prior art keywords
pharmaceutical compositions
mometasone furoate
making same
furoate monohydrate
monohydrate
Prior art date
Application number
OA60348A
Other languages
English (en)
Inventor
Pui-Ho Yuen
Charles Eckhart
Teresa Etlinger
Nancy Levine
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA09772(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of OA09772A publication Critical patent/OA09772A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
OA60348A 1990-09-10 1993-03-09 "mometasone furoate monohydrate, process for making same and pharmaceutical compositions". OA09772A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58023990A 1990-09-10 1990-09-10

Publications (1)

Publication Number Publication Date
OA09772A true OA09772A (en) 1993-11-30

Family

ID=24320279

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60348A OA09772A (en) 1990-09-10 1993-03-09 "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".

Country Status (35)

Country Link
US (1) US6180781B1 (OSRAM)
EP (1) EP0548114B1 (OSRAM)
JP (1) JPH0725789B2 (OSRAM)
KR (1) KR960013445B1 (OSRAM)
CN (1) CN1030920C (OSRAM)
AT (1) ATE113604T1 (OSRAM)
AU (1) AU663471B2 (OSRAM)
BG (1) BG60755B2 (OSRAM)
CA (1) CA2091360C (OSRAM)
CZ (1) CZ281318B6 (OSRAM)
DE (2) DE69104991T2 (OSRAM)
DK (1) DK0548114T5 (OSRAM)
EE (1) EE02962B1 (OSRAM)
ES (1) ES2065701T3 (OSRAM)
FI (1) FI111078B (OSRAM)
HK (1) HK185996A (OSRAM)
HR (1) HRP920383B1 (OSRAM)
HU (1) HU213401B (OSRAM)
IE (1) IE67056B1 (OSRAM)
IL (1) IL99437A (OSRAM)
LU (1) LU90366I2 (OSRAM)
MX (2) MX9203396A (OSRAM)
MY (1) MY106644A (OSRAM)
NL (1) NL980012I2 (OSRAM)
NO (1) NO300548B1 (OSRAM)
NZ (1) NZ239711A (OSRAM)
OA (1) OA09772A (OSRAM)
PH (1) PH30443A (OSRAM)
PL (1) PL165803B1 (OSRAM)
PT (1) PT98905B (OSRAM)
SI (1) SI9111497A (OSRAM)
TW (2) TW229208B (OSRAM)
WO (1) WO1992004365A1 (OSRAM)
YU (1) YU48666B (OSRAM)
ZA (1) ZA917148B (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9203396A (es) * 1990-09-10 1992-07-31 Schering Corp Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas.
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CN1059476C (zh) * 1996-08-21 2000-12-13 邓维鹏 金黄色铝合金硒盐电解着色方法
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
JP3676674B2 (ja) * 1997-10-09 2005-07-27 シェーリング コーポレイション 噴霧のためのモメタゾンフロエート懸濁液
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
CN1250563C (zh) 1999-05-04 2006-04-12 斯特拉坎有限公司 雄激素糖苷及其产生雄性征的活性
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
EP1663999A2 (en) * 2003-08-29 2006-06-07 Ranbaxy Laboratories, Ltd. Inhibitors of phosphodiesterase type-iv
EP1694655A2 (en) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
EP1934219A1 (en) 2005-09-16 2008-06-25 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
BRPI0617674A2 (pt) 2005-10-19 2011-08-02 Ranbaxy Lab Ltd composições farmacêuticas e seus usos
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
EA200900472A1 (ru) * 2006-09-22 2009-10-30 Ранбакси Лабораторис Лимитед Ингибиторы фосфодиэстеразы iv типа
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
HRP20120361T1 (hr) 2007-03-14 2012-05-31 Ranbaxy Laboratories Limited DERIVATI PIRAZOLO[3,4-b]PIRIDINA KAO INHIBITORI FOSFODIESTERAZE
WO2008111009A1 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US8815258B2 (en) * 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
SI2435024T1 (sl) 2009-05-29 2016-10-28 Pearl Therapeutics, Inc. Zmesi za respiratorni vnos aktivnih sredstev in s tem povezane metode in sistemi
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
EP2968152B2 (en) 2013-03-15 2022-06-22 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
CN107260671B (zh) * 2016-04-08 2021-03-26 天津金耀集团有限公司 一种糠酸莫米松混悬鼻喷剂组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0057401B1 (en) * 1981-02-02 1984-08-01 Schering Corporation Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4783444A (en) 1984-09-17 1988-11-08 Schering Corporation Antiglaucoma compositions and methods
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
MX9203396A (es) * 1990-09-10 1992-07-31 Schering Corp Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas.

Also Published As

Publication number Publication date
US6180781B1 (en) 2001-01-30
TW272195B (OSRAM) 1996-03-11
HRP920383B1 (en) 2000-04-30
KR960013445B1 (ko) 1996-10-05
FI931031A0 (fi) 1993-03-09
TW229208B (OSRAM) 1994-09-01
JPH05506667A (ja) 1993-09-30
LU90366I2 (fr) 1999-05-05
MX9203396A (es) 1992-07-31
PH30443A (en) 1997-05-09
EP0548114B1 (en) 1994-11-02
AU663471B2 (en) 1995-10-12
CN1030920C (zh) 1996-02-07
HU9300685D0 (en) 1993-06-28
NZ239711A (en) 1992-09-25
DE19875032I2 (de) 2007-04-19
HK185996A (en) 1996-10-11
DE69104991T2 (de) 1995-04-20
MY106644A (en) 1995-07-31
ATE113604T1 (de) 1994-11-15
SI9111497A (sl) 1998-04-30
PL165803B1 (pl) 1995-02-28
CZ281318B6 (cs) 1996-08-14
CA2091360C (en) 1997-04-08
YU149791A (sh) 1994-01-20
MX9100990A (es) 1992-05-04
DK0548114T5 (da) 1995-01-30
IL99437A0 (en) 1992-08-18
ES2065701T3 (es) 1995-02-16
JPH0725789B2 (ja) 1995-03-22
WO1992004365A1 (en) 1992-03-19
YU48666B (sh) 1999-06-15
HUT64361A (en) 1993-12-28
EP0548114A1 (en) 1993-06-30
CZ38393A3 (en) 1994-01-19
FI111078B (fi) 2003-05-30
DE69104991D1 (de) 1994-12-08
EE02962B1 (et) 1997-02-17
CA2091360A1 (en) 1992-03-11
BG60755B2 (bg) 1996-02-29
PT98905B (pt) 1998-08-31
NO300548B1 (no) 1997-06-16
NL980012I1 (nl) 1998-05-06
IE67056B1 (en) 1996-02-21
ZA917148B (en) 1992-08-26
HU213401B (en) 1997-06-30
NO930693D0 (no) 1993-02-26
AU8497491A (en) 1992-03-30
IL99437A (en) 1995-05-29
HRP920383A2 (en) 1998-06-30
NL980012I2 (nl) 2004-11-01
PT98905A (pt) 1992-09-30
FI931031L (fi) 1993-03-09
CN1059911A (zh) 1992-04-01
IE913155A1 (en) 1992-03-11
NO930693L (no) 1993-02-26

Similar Documents

Publication Publication Date Title
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
ES8307794A1 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
IT8219908A0 (it) Derivati di ferro biodisponibile esenti da gastrolesivita',procedimento di preparazione e relative composizioni farmaceutiche.
CA2152771A1 (en) 7-o-ethers of taxane derivatives
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
HUT73529A (en) New bis-naphthalimides for the treatment of cancer
IL99898A0 (en) 7-acyl-3-substituted carbamoyloxy cephem compounds,their preparation and antibacterial compositions containing them
ES8504166A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz(b,e) oxepina.
PL286188A1 (en) Method of obtaining renine retarding aminooligohydroxy derivatives
IL66192A (en) Albomycin derivatives,their production and pharmaceutical compositions containing them
GR910300116T1 (en) 3-l-(5-thioxo-l-prolyl)thiazolidine-4-carboxylic acid and derivatives therefrom, processes for the preparation thereof and pharmaceutical compositions containing them
JO1711B1 (en) Therapeutic agents
ZA912180B (en) Novel compounds.cephalosporins,process for their preparation and pharmaceutical compositions containing them
IL97715A0 (en) Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer,process for the preparation thereof,and pharmaceutical compositions containing the same
HU00224A9 (en) Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
IT1255696B (it) Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono